159 related articles for article (PubMed ID: 8025739)
1. Compartmentalized immune response reflects clinical severity of beryllium disease.
Newman LS; Bobka C; Schumacher B; Daniloff E; Zhen B; Mroz MM; King TE
Am J Respir Crit Care Med; 1994 Jul; 150(1):135-42. PubMed ID: 8025739
[TBL] [Abstract][Full Text] [Related]
2. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history.
Newman LS; Kreiss K; King TE; Seay S; Campbell PA
Am Rev Respir Dis; 1989 Jun; 139(6):1479-86. PubMed ID: 2729754
[TBL] [Abstract][Full Text] [Related]
3. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease.
Tinkle SS; Newman LS
Am J Respir Crit Care Med; 1997 Dec; 156(6):1884-91. PubMed ID: 9412570
[TBL] [Abstract][Full Text] [Related]
4. Serum angiotensin converting enzyme activity in chronic beryllium disease.
Newman LS; Orton R; Kreiss K
Am Rev Respir Dis; 1992 Jul; 146(1):39-42. PubMed ID: 1320822
[TBL] [Abstract][Full Text] [Related]
5. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.
Mack DG; Lanham AM; Falta MT; Palmer BE; Maier LA; Fontenot AP
Am J Respir Crit Care Med; 2010 Jun; 181(11):1241-9. PubMed ID: 20299529
[TBL] [Abstract][Full Text] [Related]
6. CD57 expression correlates with alveolitis severity in subjects with beryllium-induced disease.
Palmer BE; Mack DG; Martin AK; Maier LA; Fontenot AP
J Allergy Clin Immunol; 2007 Jul; 120(1):184-91. PubMed ID: 17416406
[TBL] [Abstract][Full Text] [Related]
7. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386
[TBL] [Abstract][Full Text] [Related]
8. Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease.
Fontenot AP; Kotzin BL; Comment CE; Newman LS
Am J Respir Cell Mol Biol; 1998 Apr; 18(4):581-9. PubMed ID: 9533947
[TBL] [Abstract][Full Text] [Related]
9. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
Tinkle SS; Kittle LA; Newman LS
J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
[TBL] [Abstract][Full Text] [Related]
10. Self-presentation of beryllium by BAL CD4+ T cells: T cell-T cell interactions and their potential role in chronic beryllium disease.
Fontenot AP; Edwards DM; Chou YK; Mack DG; LaTocha D; Vandenbark AA; Burrows GG
Eur J Immunol; 2006 Apr; 36(4):930-9. PubMed ID: 16552706
[TBL] [Abstract][Full Text] [Related]
11. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP.
Sawyer RT; Parsons CE; Fontenot AP; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Newman LS
Am J Respir Cell Mol Biol; 2004 Jul; 31(1):122-30. PubMed ID: 14975942
[TBL] [Abstract][Full Text] [Related]
12. Early pulmonary physiologic abnormalities in beryllium disease.
Pappas GP; Newman LS
Am Rev Respir Dis; 1993 Sep; 148(3):661-6. PubMed ID: 8368637
[TBL] [Abstract][Full Text] [Related]
13. Beryllium stimulates release of T helper 1 cytokines interleukin-2 and interferon gamma from BAL cells in chronic beryllium disease.
Tinkle S; Kittle L; Schwitters PW; Addison JR; Newman LS
Chest; 1996 Mar; 109(3 Suppl):5S-6S. PubMed ID: 8598153
[No Abstract] [Full Text] [Related]
14. Beryllium induces IL-2 and IFN-gamma in berylliosis.
Tinkle SS; Kittle LA; Schumacher BA; Newman LS
J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230
[TBL] [Abstract][Full Text] [Related]
15. IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis.
Maier LA; Sawyer RT; Tinkle SS; Kittle LA; Barker EA; Balkissoon R; Rose C; Newman LS
Eur Respir J; 2001 Mar; 17(3):403-15. PubMed ID: 11405518
[TBL] [Abstract][Full Text] [Related]
16. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease.
Mroz MM; Kreiss K; Lezotte DC; Campbell PA; Newman LS
J Allergy Clin Immunol; 1991 Jul; 88(1):54-60. PubMed ID: 2071785
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.
Day BJ; Huang J; Barkes BQ; Gillespie M; Li L; Maier LA
Lung; 2018 Feb; 196(1):103-114. PubMed ID: 29080069
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells.
Saltini C; Winestock K; Kirby M; Pinkston P; Crystal RG
N Engl J Med; 1989 Apr; 320(17):1103-9. PubMed ID: 2469014
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease.
Palmer BE; Mack DG; Martin AK; Gillespie M; Mroz MM; Maier LA; Fontenot AP
J Immunol; 2008 Feb; 180(4):2704-12. PubMed ID: 18250483
[TBL] [Abstract][Full Text] [Related]
20. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.
Fontenot AP; Canavera SJ; Gharavi L; Newman LS; Kotzin BL
J Clin Invest; 2002 Nov; 110(10):1473-82. PubMed ID: 12438445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
